CDKN2A and acute lymphoblastic leukemia: Despite differences in clinical manifestation, T-ALL and T-LBL have an overlapping immunophenotype and recurrent genetic aberrations, such as NOTCH1 activating mutations, CDKN2A/B deletions (cell cycle defects) and loss-of-heterozygosity in chromosome 6q2,3.